课题基金 / 基金详情

Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease

Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
批准号:
10756875
负责人:
RALPH P. MASON
金额:
$5.97万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-02 至 2026-04-30

项目摘要

项目成果

RALPH P. MASON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract The long-term goal of our parent grant award is to develop novel biocompatible and biodegradable dual-modal imaging nanoparticles (DINPs) to provide cell protection and to facilitate therapeutic angiogenesis under stress conditions such as ischemia for peripheral arterial disease (PAD). For this supplement application, we propose the following approaches aimed to enrich the potential of our parent award: a) the development of fucoidan (FC) targeted nanoparticles (FC-DINPs) with optimized fluorescent and photoacoustic imaging capabilities, b) the formulation of FC-DINP loaded hydrogel angioplasty balloon coatings for simultaneous percutaneous transluminal angioplasty and local drug delivery, and c) the evaluation of FC-DINPs transfer efficacy to ex-vivo segments of porcine arteries. The main innovative aspects of our design are: 1) the simultaneous angioplasty treatment and local delivery of therapeutic agents via a mussel-inspired nanocomposite balloon coating formed by the combination of FC-DINPs and adhesive hydrogels, to ensure a homogeneous and controlled drug delivery, 2) the use of biodegradable photoluminescent polymer-aniline tetramers (BPLPAT) to fabricate FC- DINPs, 3) the use of fucoidan (FC), a high affinity targeting ligand for P-selectin overexpressed on injured endothelium, to improve FC-DINPs attachment to the target site, and 4) the use of HA-DA, an adhesive hydrogel synthesized with hyaluronic acid (HA) and dopamine (DA), to mimic the adhesive strategies of blue mussels and to confer the characteristics needed to deliver FC-DINPs from the vehicle and gain adhesion to the inner blood vessel wall. Furthermore, this proposal focuses on promoting diversity, equity, inclusion, and accessibility (DEIA). Our proposed research approaches for the treatment of PAD are within the scope of the parent grant (“Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease”) and will help to foster the research career development of Ms. Ingrid D. Guerrero Rodriguez, a doctoral student from underrepresented minorities (URM) with a disadvantaged background and a physical disability. She will be mentored and supported by the PI, Dr. Kytai T. Nguyen, a researcher and educator with a proven record of her commitment to the advancement of minority students in STEM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
  • 批准号:
    10462909
  • 项目类别:
  • 资助金额:
    $53.67万
  • 财政年份:
    2022
  • 负责人:
    RALPH P. MASON
  • 依托单位:
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
  • 批准号:
    10616740
  • 项目类别:
  • 资助金额:
    $53.03万
  • 财政年份:
    2022
  • 负责人:
    RALPH P. MASON
  • 依托单位:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
  • 批准号:
    10646312
  • 项目类别:
  • 资助金额:
    $48.08万
  • 财政年份:
    2020
  • 负责人:
    RALPH P. MASON
  • 依托单位:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
  • 批准号:
    10442463
  • 项目类别:
  • 资助金额:
    $46.63万
  • 财政年份:
    2020
  • 负责人:
    RALPH P. MASON
  • 依托单位:
海外基金